(Q80847641)
Statements
PGDS, a novel technique combining chromogenic in situ hybridization and immunohistochemistry for the assessment of ErbB2 (HER2/neu) status in breast cancer (English)
Ruoyu Ni
Cherry Have
Frances P O'Malley
1 September 2007